Synthesis and biological properties of 5-o-carboranyl-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)uracil Journal Article


Authors: Fulcrand-El Kattan, G.; Goudgaon, N. M.; Ilksoy, N.; Huang, J. T.; Watanabe, K. A.; Sommadossi, J. P.; Schinazi, R. F.
Article Title: Synthesis and biological properties of 5-o-carboranyl-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)uracil
Abstract: A novel 5-o-carboranyl-containing nucleoside, 5-o-carboranyl-1-(2-deoxy-2-fluoro-β-d-arabinofuranosyl) uracil (6, CFAU), was synthesized as a potential intracellular neutron capture agent. This compound was prepared in five steps starting from 5-iodo-1-(2-deoxy-2-fluoro-β-d-arabinofuranosyl) uracil (1). The desired carboranyl derivative was obtained by addition of decaborane [as the bis(propionitrile) adduct] to the protected acetylenic nucleoside precursor followed by debenzoylation. The synthesis of CFAU was also performed by glycosylation of the suitably protected 5-o-carboranyluracil with the appropriate 2-fluoroarabinosyl derivative. This compound was evaluated for its cytotoxicity in human lymphocytes, monkey cells, and rat and human gliomas cells, as well as for antiviral activity against human immunodeficiency virus and herpes simplex virus type 1. Its biological activity was compared to 5-o-carboranyl-1-(2-deoxyribofuranosyl)uracil in these cell culture systems, human bone marrow cells, and mice. The results obtained to date suggest that CFAU has suitable characteristics as a sensitizer for boron neutron capture therapy. © 1994, American Chemical Society. All rights reserved.
Keywords: controlled study; unclassified drug; human cell; dose response; nonhuman; human immunodeficiency virus infection; glioma; animal cell; mouse; animal; mice; cell survival; melanoma; bone marrow; animal experiment; cytotoxicity; drug structure; tumor cells, cultured; drug synthesis; glycosylation; uracil arabinoside; arabinofuranosyluracil; herpesvirus 1, human; rats; radiation-sensitizing agents; lymphocytes; herpes simplex virus 1; cancer cell destruction; antiviral activity; colony forming unit gm; vero cell; hiv-1; zidovudine; antiviral agents; boron compounds; burst forming unit e; neutron capture therapy; human; female; article; boron neutron capture therapy; fluorouracil derivative; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; support, u.s. gov't, non-p.h.s.; 5 carboranyl 2' deoxyuridine; 5 o carboranyl 1 (2 deoxy 2 fluoro beta d arabinofuranosyl)uracil; carborane derivative
Journal Title: Journal of Medicinal Chemistry
Volume: 37
Issue: 16
ISSN: 0022-2623
Publisher: American Chemical Society  
Date Published: 1994-08-05
Start Page: 2583
End Page: 2588
Language: English
DOI: 10.1021/jm00042a011
PROVIDER: scopus
PUBMED: 8057301
DOI/URL:
Notes: Jai-Tung Huang's name is misspelled on the original publication -- Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kyoichi A Watanabe
    125 Watanabe